 |
PDBsum entry 1nlp
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Complex (transferase/peptide)
|
PDB id
|
|
|
|
1nlp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Chem Biol
3:661-670
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular basis for the binding of SH3 ligands with non-peptide elements identified by combinatorial synthesis.
|
|
S.Feng,
T.M.Kapoor,
F.Shirai,
A.P.Combs,
S.L.Schreiber.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Protein-structure-based combinatorial chemistry has recently been
used to discover several ligands containing non-peptide binding elements to the
Src SH3 domain. The encoded library used has the form Cap-M1-M2-M3-PLPPLP, in
which the Cap and Mi's are composed of a diverse set of organic monomers. The
PLPPLP portion provided a structural bias directing the non-peptide fragment
Cap-M1-M2-M3 to the SH3 specificity pocket. Fifteen ligands were selected from
> 1.1 million distinct compounds. The structural basis for selection was
unknown. RESULTS: The solution structures of the Src SH3 domain complexed with
two ligands containing non-peptide elements selected from the library were
determined by multidimensional NMR spectroscopy. The non-peptide moieties of the
ligands interact with the specificity pocket of Src SH3 domain differently from
peptides complexed with SH3 domains. Structural information about the ligands
was used to design various homologs, whose affinities for the SH3 domain were
measured. The results provide a structural basis for understanding the selection
of a few optimal ligands from a large library. CONCLUSIONS: The cycle of
protein-structure-based combinatorial chemistry followed by structure
determination of the few highest affinity ligands provides a powerful new tool
for the field of molecular recognition.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Hoffmann,
S.A.Funke,
K.Wiesehan,
S.Moedder,
J.M.Glück,
S.Feuerstein,
M.Gerdts,
J.Mötter,
and
D.Willbold
(2010).
Competitively selected protein ligands pay their increase in specificity by a decrease in affinity.
|
| |
Mol Biosyst,
6,
116-123.
|
 |
|
|
|
|
 |
S.R.McGuffee,
and
A.H.Elcock
(2010).
Diffusion, crowding & protein stability in a dynamic molecular model of the bacterial cytoplasm.
|
| |
PLoS Comput Biol,
6,
e1000694.
|
 |
|
|
|
|
 |
F.Ding,
K.C.Prutzman,
S.L.Campbell,
and
N.V.Dokholyan
(2006).
Topological determinants of protein domain swapping.
|
| |
Structure,
14,
5.
|
 |
|
|
|
|
 |
F.Ding,
and
N.V.Dokholyan
(2006).
Emergence of protein fold families through rational design.
|
| |
PLoS Comput Biol,
2,
e85.
|
 |
|
|
|
|
 |
L.J.Ball,
R.Kühne,
J.Schneider-Mergener,
and
H.Oschkinat
(2005).
Recognition of Proline-Rich Motifs by Protein-Protein-Interaction Domains.
|
| |
Angew Chem Int Ed Engl,
44,
2852-2869.
|
 |
|
|
|
|
 |
W.Cai,
J.Pei,
and
N.V.Grishin
(2004).
Reconstruction of ancestral protein sequences and its applications.
|
| |
BMC Evol Biol,
4,
33.
|
 |
|
|
|
|
 |
F.Santamaria,
Z.Wu,
C.Boulègue,
G.Pál,
and
W.Lu
(2003).
Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
|
| |
J Mol Recognit,
16,
131-138.
|
 |
|
|
|
|
 |
M.Vidal,
V.Gigoux,
and
C.Garbay
(2001).
SH2 and SH3 domains as targets for anti-proliferative agents.
|
| |
Crit Rev Oncol Hematol,
40,
175-186.
|
 |
|
|
|
|
 |
B.Aghazadeh,
and
M.K.Rosen
(1999).
Ligand recognition by SH3 and WW domains: the role of N-alkylation in PPII helices.
|
| |
Chem Biol,
6,
R241-R246.
|
 |
|
|
|
|
 |
J.C.Albrecht,
U.Friedrich,
C.Kardinal,
J.Koehn,
B.Fleckenstein,
S.M.Feller,
and
B.Biesinger
(1999).
Herpesvirus ateles gene product Tio interacts with nonreceptor protein tyrosine kinases.
|
| |
J Virol,
73,
4631-4639.
|
 |
|
|
|
|
 |
D.C.Dalgarno,
M.C.Botfield,
and
R.J.Rickles
(1997).
SH3 domains and drug design: ligands, structure, and biological function.
|
| |
Biopolymers,
43,
383-400.
|
 |
|
|
|
|
 |
H.V.Patel,
S.R.Tzeng,
C.Y.Liao,
S.H.Chen,
and
J.W.Cheng
(1997).
SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
|
| |
Proteins,
29,
545-552.
|
 |
|
|
|
|
 |
R.E.Hubbard
(1997).
Can drugs be designed?
|
| |
Curr Opin Biotechnol,
8,
696-700.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |